Hemorrhage With Anticoagulants and Antiplatelets in Vitreoretinal Surgery

摘要

EDITOR:WE READ WITH GREAT INTEREST THE ARTICLE BY OH AND associates, which adds further debate to the question of the management of antiplatelet and anticoagulant medication in patients undergoing vitreoretinal surgery.Traditional beliefs suggest that platelets and factors affecting primary hemostasis are more crucial than suppression of clotting factors through anticoagulants in minute surgical trauma such as intraocular surgery. The converse is thought to be true in moderate or severe surgical trauma (such as ocular muscle and lid surgery). However, Oh and associates suggest that anticoagulation is a risk factor for vitreous hemorrhage occurring after vitrectomy, whereas antiplatelet medication poses no increased risk.